Allen Chaves - Sep 20, 2023 Form 3 Insider Report for Klaviyo, Inc. (KVYO)

Role
Chief Technology Officer
Signature
/s/ Landon Edmond, Attorney-in-Fact
Stock symbol
KVYO
Transactions as of
Sep 20, 2023
Transactions value $
$0
Form type
3
Date filed
9/20/2023, 04:37 PM
Next filing
Feb 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding KVYO Series B Common Stock Sep 20, 2023 Series A Common Stock 228K Direct F1, F2
holding KVYO Stock Option (Right to Buy) Sep 20, 2023 Series B Common Stock 1.32M $3.06 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock of the Issuer, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
F2 Amount consists of (a) 65,466 shares of Series B Common Stock and (b) 162,500 unvested RSUs awarded under the 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. The RSUs vest as follows: 108,875 RSUs vest in four equal quarterly installments beginning on February 15, 2024, and the remaining 53,625 RSUs vest in four equal quarterly installments beginning on February 15, 2025, subject to the Reporting Persons continued service on each such vesting date.
F3 25% of the shares subject to this option vested and became exercisable on December 27, 2020, with the remainder vesting in thirty-six equal monthly installments thereafter, subject to the Reporting Persons continued service on each such vesting date.

Remarks:

Exhibit 24 Power of Attorney